The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C

Journal of Viral Hepatitis

Volumn 11, Issue 1, 2004, Pages 91-96

  Piche, T ^a,b   Vandenbos, F ^a   Abakar Mahamat, A ^a   Vanbiervliet, G ^a   Barjoan, E M ^a   Calle, G ^a   Giudicelli, J ^a   Ferrua, B ^a   Laffont, C ^a   Benzaken, S ^a   Tran, A ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Chronic hepatitis C; Leptin; Liver fibrosis

Indexed keywords

FERRITIN; GLUCOSE; LEPTIN; PROTHROMBIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SEX DIFFERENCE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LEPTIN; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10744231005     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00483.x     Document Type: Article

References (42)

1. Poynard T, Bedossa P, Opolon P and the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
2. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145.
3. Angulo P, Keach JC, Batts K, Lindor KD. Independent predictors of liver fibrosis in patients with non alcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
4. Fischer HP, Willisch E, Bierhoff E, Pfeifer U. Histopathological findings in chronic hepatitis C. J Hepatol 1996; 24: 35-42.
5. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis C: a comparative analysis. Hepatology 1992; 15: 572-577.
6. Lefkowitch JH, Schiff ER, Davis RL et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595-603.
7. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-571.
8. Czaja A, Carpenter HA, Santrach PJ, Moore SB. Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29: 198-206.
9. Fujie H, Yotsuyanagi H, Moriya K et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 1999; 59: 141-145.
10. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364.
11. Hourigan LF, Macdonald GA, Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
12. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
13. Zhang Y, Procnca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
14. Piche T, Gelsi E, Schneider SM et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2002; 51: 434-439.
15. Testa R, Franceschini R, Gianninni E et al. Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol 2000; 33: 33-37.
16. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
17. Muller G, Ertl J, Gerl M, Prelbisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 138: 10585-10593.
18. Sanyal AJ, Campbell-Sergent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192.
19. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998; 244: 178-182.
20. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998; 115: 997-1001.
21. Ikejima K, Takei Y, Honda H et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122: 1399-1410.
22. Grunfeld C, Zhao C, Fuller J et al. Endotoxin and cytokine induce expression of leptin, the OB gene product, in hamster. A role for leptin in the anorexia of infection. J Clin Invest 1996; 97: 2152-2157.
23. Nelson DR, Lim HL, Marousis CG et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 1997; 42: 2487-2494.
24. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoolic steatohepatitis. N Engl J Med 2000; 343: 1467-1476.
25. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α - and obesity-induced insulin resistance. Science 1996; 271: 665-668.
26. Valenti L, Fracanzani L, Dongiovanni P et al. Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 274-280.
27. The French METAVIR cooperative study group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
28. Rubbia-Brandt L, Quadri R et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33: 106-115.
29. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98-106.
30. Diehl AM, Goodman Z, Ishak KG. Alcohol like liver disease in nonalcoholics. A clinical and histological comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-1062.
31. Lee RG. Nonalcoholic steatohepatitis. Hum Pathol 1989; 20: 594-598.
32. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty two patients for up to 21 years Hepatology 1990; 11: 74-80.
33. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC. Gender-dependent alteration in serum leptin in alcoholic cirrhosis. Gastroenterology 1998; 115: 947-953.
34. Ockenga J, Bischoff C, Tillmann HL et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000; 119: 1656-1662.
35. Shimizu H, Kakizaki S, Tsuchiya T, Naagamine T, Tagaki H, Takayama H. An increase of circulating leptin in patients with liver cirrhosis. Int J Obes Relat Metab Disord 1998; 22: 1234-1238.
36. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and adiposal. Hepatology 1999; 29: 1818-1824.
37. Giannini E, Ceppa P, Botta F et al. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2000; 95: 3211-3217.
38. Loffreda S, Yang SQ, Lin HZ et al. Leptin regulates proinflammatory immune response. FASEB J 1998; 12: 57-65.
39. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buscenfelde KH, Rittner C. Tumor necrosis factor promoter polymorphism at position-238 is associated with chronic active hepatitis C infection. J Med Virol 1998; 54: 173-177.
40. Cookson S, Constantini PK, Clare M et al. Frequency and nature of cytokine gene polymorphism in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-856.
41. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 1989; 337: 661-663.
42. Hickman IJ, Clouston AD, Macdonald GA et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51: 89-94.